Ovid Therapeutics Inc (NASDAQ:OVID)

5.84
Delayed Data
As of May 22
 +0.75 / +14.73%
Today’s Change
1.53
Today|||52-Week Range
6.11
+40.72%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 10.30, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +76.37% increase from the last price of 5.84.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$0.00
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.34%
 
 
 
 
 
 
Growthannually 10.70%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.